US Stock MarketDetailed Quotes

GEF Greif

Watchlist

61.990
+0.630+1.03%

Trading May 2 12:10 ET

3.58BMarket Cap10.72P/E (TTM)

Greif Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Jan 31, 2024

(FY)Oct 31, 2023

(Q4)Oct 31, 2023

(Q3)Jul 31, 2023

(Q2)Apr 30, 2023

(Q1)Jan 31, 2023

(FY)Oct 31, 2022

(Q4)Oct 31, 2022

(Q3)Jul 31, 2022

(Q2)Apr 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-86.32%4.5M

-1.22%649.5M

-29.00%203.5M

-3.34%202.3M

51.44%210.8M

46.88%32.9M

66.04%657.5M

108.74%286.6M

120.55%209.3M

-8.60%139.2M

Net income from continuing operations

-20.19%74.3M

-3.78%379.1M

-28.56%73.3M

-33.81%96.7M

-8.45%116M

400.54%93.1M

-4.65%394M

-6.64%102.6M

23.40%146.1M

-17.73%126.7M

Operating gains losses

108.99%4.9M

-537.39%-50.3M

151.85%13.6M

123.64%1.3M

-211.46%-10.7M

-2,825.00%-54.5M

112.91%11.5M

384.21%5.4M

-103.70%-5.5M

110.16%9.6M

Depreciation and amortization

9.62%60.4M

6.46%230.6M

19.53%61.2M

12.26%57.7M

3.66%56.6M

-7.24%55.1M

-7.59%216.6M

-12.03%51.2M

-11.53%51.4M

-7.14%54.6M

Deferred tax

-7,128.57%-49.2M

-314.18%-28.7M

-250.27%-27.8M

59.68%-2.5M

200.00%900K

-65.00%700K

128.39%13.4M

430.36%18.5M

-6,100.00%-6.2M

97.73%-900K

Other non cash items

-5.22%12.7M

10.14%40.2M

-35.63%5.6M

-1.67%11.8M

1,466.67%9.4M

-11.84%13.4M

-2.93%36.5M

987.50%8.7M

7.14%12M

-93.55%600K

Change In working capital

-32.49%-99.9M

168.19%58.3M

-34.24%60.7M

230.56%35.7M

172.57%37.3M

45.04%-75.4M

47.16%-85.5M

393.02%92.3M

112.00%10.8M

-180.19%-51.4M

-Change in receivables

-80.80%21.5M

419.12%130.3M

-80.71%20.8M

825.53%43.5M

44.31%-46M

2,433.33%112M

110.14%25.1M

273.59%107.8M

105.40%4.7M

-22.19%-82.6M

-Change in inventory

-976.92%-28M

1,555.74%101M

-26.37%51.1M

259.15%11.3M

514.93%41.2M

95.87%-2.6M

102.97%6.1M

244.28%69.4M

91.75%-7.1M

118.66%6.7M

-Change in payables and accrued expense

79.53%-21.1M

-97.04%-79.8M

83.70%-14.2M

-94.63%1.3M

182.81%36.2M

-1,173.96%-103.1M

-117.58%-40.5M

-431.18%-87.1M

-69.09%24.2M

-88.58%12.8M

-Change in other working capital

11.51%-72.3M

-22.31%-93.2M

36.36%3M

-85.45%-20.4M

-49.57%5.9M

-3.29%-81.7M

-225.12%-76.2M

-95.80%2.2M

-329.17%-11M

-78.92%11.7M

Cash from discontinued investing activities

Operating cash flow

-86.32%4.5M

-1.22%649.5M

-29.00%203.5M

-3.34%202.3M

51.44%210.8M

46.88%32.9M

66.04%657.5M

108.74%286.6M

120.55%209.3M

-8.60%139.2M

Investing cash flow

Cash flow from continuing investing activities

80.08%-53.6M

-2,276.60%-670.2M

-175.83%-173.5M

-63.21%-45.7M

-267.65%-181.9M

-487.55%-269.1M

-160.26%-28.2M

-59.64%-62.9M

12.77%-28M

-4.91%108.5M

Net PPE purchase and sale

-2.54%-52.4M

-29.69%-211M

-24.32%-78.2M

-62.14%-45.4M

-18.24%-36.3M

-24.33%-51.1M

-1,262.14%-162.7M

-56.47%-62.9M

8.79%-28M

-127.10%-30.7M

Net business purchase and sale

99.45%-1.2M

-441.41%-459.2M

---95.3M

---300K

-204.60%-145.6M

-4,538.30%-218M

13,550.00%134.5M

--0

--139.2M

Cash from discontinued investing activities

Investing cash flow

80.08%-53.6M

-2,276.60%-670.2M

-175.83%-173.5M

-63.21%-45.7M

-267.65%-181.9M

-487.55%-269.1M

-160.26%-28.2M

-59.64%-62.9M

12.77%-28M

-4.91%108.5M

Financing cash flow

Cash flow from continuing financing activities

-84.93%36.1M

113.13%69.7M

104.11%7.7M

-4.70%-153.6M

90.48%-23.9M

343.52%239.5M

-25.56%-531M

-172.09%-187.2M

-119.94%-146.7M

2.45%-251.1M

Net issuance payments of debt

-75.56%74.1M

200.55%290.7M

134.07%47.6M

-218.33%-118.1M

129.55%58M

260.95%303.2M

-8.68%-289.1M

-242.40%-139.7M

2.88%-37.1M

13.79%-196.3M

Net common stock issuance

--0

10.13%-63.9M

--0

92.83%-4.3M

---41.8M

---17.8M

---71.1M

---11.1M

---60M

--0

Cash dividends paid

-2.77%-29.7M

-4.67%-116.5M

-1.71%-29.8M

-5.11%-28.8M

-5.84%-29M

-6.25%-28.9M

-5.20%-111.3M

-6.93%-29.3M

-4.58%-27.4M

-4.18%-27.4M

Net other financing activities

51.18%-8.3M

31.76%-40.6M

-42.25%-10.1M

89.19%-2.4M

59.49%-11.1M

-507.14%-17M

-16.44%-59.5M

-1,083.33%-7.1M

-865.22%-22.2M

-705.88%-27.4M

Cash from discontinued financing activities

Financing cash flow

-84.93%36.1M

113.13%69.7M

104.11%7.7M

-4.70%-153.6M

90.48%-23.9M

343.52%239.5M

-25.56%-531M

-172.09%-187.2M

-119.94%-146.7M

2.45%-251.1M

Net cash flow

Beginning cash position

22.98%180.9M

18.06%147.1M

23.69%157.7M

45.81%158.5M

17.86%161M

18.06%147.1M

17.66%124.6M

27.76%127.5M

-1.54%108.7M

34.71%136.6M

Current changes in cash

-493.94%-13M

-50.15%49M

3.29%37.7M

-91.33%3M

247.06%5M

-89.22%3.3M

381.86%98.3M

23.31%36.5M

987.18%34.6M

-137.78%-3.4M

Effect of exchange rate changes

7.55%11.4M

79.95%-15.2M

14.20%-14.5M

75.95%-3.8M

69.39%-7.5M

156.99%10.6M

-4,358.82%-75.8M

-252.08%-16.9M

-135.82%-15.8M

---24.5M

End cash Position

11.37%179.3M

22.98%180.9M

23.69%157.7M

45.81%158.5M

17.86%161M

18.06%147.1M

27.76%127.5M

-1.54%108.7M

Free cash flow

-182.89%-52.9M

-9.40%429.9M

-43.42%124.7M

-9.73%155.8M

55.07%168.1M

30.48%-18.7M

90.79%474.5M

140.61%220.4M

222.62%172.6M

-10.04%108.4M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Jan 31, 2024	(FY)Oct 31, 2023	(Q4)Oct 31, 2023	(Q3)Jul 31, 2023	(Q2)Apr 30, 2023	(Q1)Jan 31, 2023	(FY)Oct 31, 2022	(Q4)Oct 31, 2022	(Q3)Jul 31, 2022	(Q2)Apr 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-86.32%4.5M	-1.22%649.5M	-29.00%203.5M	-3.34%202.3M	51.44%210.8M	46.88%32.9M	66.04%657.5M	108.74%286.6M	120.55%209.3M	-8.60%139.2M
Net income from continuing operations	-20.19%74.3M	-3.78%379.1M	-28.56%73.3M	-33.81%96.7M	-8.45%116M	400.54%93.1M	-4.65%394M	-6.64%102.6M	23.40%146.1M	-17.73%126.7M
Operating gains losses	108.99%4.9M	-537.39%-50.3M	151.85%13.6M	123.64%1.3M	-211.46%-10.7M	-2,825.00%-54.5M	112.91%11.5M	384.21%5.4M	-103.70%-5.5M	110.16%9.6M
Depreciation and amortization	9.62%60.4M	6.46%230.6M	19.53%61.2M	12.26%57.7M	3.66%56.6M	-7.24%55.1M	-7.59%216.6M	-12.03%51.2M	-11.53%51.4M	-7.14%54.6M
Deferred tax	-7,128.57%-49.2M	-314.18%-28.7M	-250.27%-27.8M	59.68%-2.5M	200.00%900K	-65.00%700K	128.39%13.4M	430.36%18.5M	-6,100.00%-6.2M	97.73%-900K
Other non cash items	-5.22%12.7M	10.14%40.2M	-35.63%5.6M	-1.67%11.8M	1,466.67%9.4M	-11.84%13.4M	-2.93%36.5M	987.50%8.7M	7.14%12M	-93.55%600K
Change In working capital	-32.49%-99.9M	168.19%58.3M	-34.24%60.7M	230.56%35.7M	172.57%37.3M	45.04%-75.4M	47.16%-85.5M	393.02%92.3M	112.00%10.8M	-180.19%-51.4M
-Change in receivables	-80.80%21.5M	419.12%130.3M	-80.71%20.8M	825.53%43.5M	44.31%-46M	2,433.33%112M	110.14%25.1M	273.59%107.8M	105.40%4.7M	-22.19%-82.6M
-Change in inventory	-976.92%-28M	1,555.74%101M	-26.37%51.1M	259.15%11.3M	514.93%41.2M	95.87%-2.6M	102.97%6.1M	244.28%69.4M	91.75%-7.1M	118.66%6.7M
-Change in payables and accrued expense	79.53%-21.1M	-97.04%-79.8M	83.70%-14.2M	-94.63%1.3M	182.81%36.2M	-1,173.96%-103.1M	-117.58%-40.5M	-431.18%-87.1M	-69.09%24.2M	-88.58%12.8M
-Change in other working capital	11.51%-72.3M	-22.31%-93.2M	36.36%3M	-85.45%-20.4M	-49.57%5.9M	-3.29%-81.7M	-225.12%-76.2M	-95.80%2.2M	-329.17%-11M	-78.92%11.7M
Cash from discontinued investing activities
Operating cash flow	-86.32%4.5M	-1.22%649.5M	-29.00%203.5M	-3.34%202.3M	51.44%210.8M	46.88%32.9M	66.04%657.5M	108.74%286.6M	120.55%209.3M	-8.60%139.2M
Investing cash flow
Cash flow from continuing investing activities	80.08%-53.6M	-2,276.60%-670.2M	-175.83%-173.5M	-63.21%-45.7M	-267.65%-181.9M	-487.55%-269.1M	-160.26%-28.2M	-59.64%-62.9M	12.77%-28M	-4.91%108.5M
Net PPE purchase and sale	-2.54%-52.4M	-29.69%-211M	-24.32%-78.2M	-62.14%-45.4M	-18.24%-36.3M	-24.33%-51.1M	-1,262.14%-162.7M	-56.47%-62.9M	8.79%-28M	-127.10%-30.7M
Net business purchase and sale	99.45%-1.2M	-441.41%-459.2M	---95.3M	---300K	-204.60%-145.6M	-4,538.30%-218M	13,550.00%134.5M	--0	--0	--139.2M
Cash from discontinued investing activities
Investing cash flow	80.08%-53.6M	-2,276.60%-670.2M	-175.83%-173.5M	-63.21%-45.7M	-267.65%-181.9M	-487.55%-269.1M	-160.26%-28.2M	-59.64%-62.9M	12.77%-28M	-4.91%108.5M
Financing cash flow
Cash flow from continuing financing activities	-84.93%36.1M	113.13%69.7M	104.11%7.7M	-4.70%-153.6M	90.48%-23.9M	343.52%239.5M	-25.56%-531M	-172.09%-187.2M	-119.94%-146.7M	2.45%-251.1M
Net issuance payments of debt	-75.56%74.1M	200.55%290.7M	134.07%47.6M	-218.33%-118.1M	129.55%58M	260.95%303.2M	-8.68%-289.1M	-242.40%-139.7M	2.88%-37.1M	13.79%-196.3M
Net common stock issuance	--0	10.13%-63.9M	--0	92.83%-4.3M	---41.8M	---17.8M	---71.1M	---11.1M	---60M	--0
Cash dividends paid	-2.77%-29.7M	-4.67%-116.5M	-1.71%-29.8M	-5.11%-28.8M	-5.84%-29M	-6.25%-28.9M	-5.20%-111.3M	-6.93%-29.3M	-4.58%-27.4M	-4.18%-27.4M
Net other financing activities	51.18%-8.3M	31.76%-40.6M	-42.25%-10.1M	89.19%-2.4M	59.49%-11.1M	-507.14%-17M	-16.44%-59.5M	-1,083.33%-7.1M	-865.22%-22.2M	-705.88%-27.4M
Cash from discontinued financing activities
Financing cash flow	-84.93%36.1M	113.13%69.7M	104.11%7.7M	-4.70%-153.6M	90.48%-23.9M	343.52%239.5M	-25.56%-531M	-172.09%-187.2M	-119.94%-146.7M	2.45%-251.1M
Net cash flow
Beginning cash position	22.98%180.9M	18.06%147.1M	23.69%157.7M	45.81%158.5M	17.86%161M	18.06%147.1M	17.66%124.6M	27.76%127.5M	-1.54%108.7M	34.71%136.6M
Current changes in cash	-493.94%-13M	-50.15%49M	3.29%37.7M	-91.33%3M	247.06%5M	-89.22%3.3M	381.86%98.3M	23.31%36.5M	987.18%34.6M	-137.78%-3.4M
Effect of exchange rate changes	7.55%11.4M	79.95%-15.2M	14.20%-14.5M	75.95%-3.8M	69.39%-7.5M	156.99%10.6M	-4,358.82%-75.8M	-252.08%-16.9M	-135.82%-15.8M	---24.5M
End cash Position	11.37%179.3M	22.98%180.9M	22.98%180.9M	23.69%157.7M	45.81%158.5M	17.86%161M	18.06%147.1M	18.06%147.1M	27.76%127.5M	-1.54%108.7M
Free cash flow	-182.89%-52.9M	-9.40%429.9M	-43.42%124.7M	-9.73%155.8M	55.07%168.1M	30.48%-18.7M	90.79%474.5M	140.61%220.4M	222.62%172.6M	-10.04%108.4M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall